Log in / Register Soon
Official Education Partner of the Delhi Medicos Premier League — free question bank for every player and college
SN1 SHORT NOTE 5M ★ High-yield

Describe the multiple endocrine neoplasia syndromes.

Pathology · 2nd Professional — Para-Clinical

Definition and Classification

Multiple endocrine neoplasia (men) syndromes are autosomal dominant disorders in which tumours or hyperplasia arise in several endocrine organs in the same patient.

SyndromeGeneComponents
Men 1 (Wermer)MEN1 on chromosome 11 — a tumour suppressor (menin)The "3 Ps" — parathyroid hyperplasia (the commonest and usually first), pancreatic endocrine tumours (gastrinoma causing zollinger–ellison syndrome, insulinoma), and pituitary adenoma (most often prolactinoma)
Men 2A (Sipple)RET on chromosome 10 — a proto-oncogeneMedullary thyroid carcinoma (over 95%), phaeochromocytoma (about 50%), and parathyroid hyperplasia
Men 2BRET (codon 918)Medullary thyroid carcinoma and phaeochromocytoma, but NO parathyroid disease; plus mucosal neuromas, intestinal ganglioneuromatosis and a marfanoid habitus

CLINICAL PEARL

Men 1 is caused by a tumour suppressor and men 2 by an oncogene, and that difference is clinically useful. A tumour suppressor needs two hits, so men 1 tumours arise sporadically over time and cannot be pre-empted. An activating oncogene mutation is present and active in every cell, so medullary carcinoma is near-inevitable in men 2 — which is why prophylactic thyroidectomy in childhood is offered to RET carriers and has no equivalent in men 1.

Clinical Presentation

  • Men 1 most often presents with hypercalcaemia from parathyroid hyperplasia — often asymptomatic and found on biochemistry
  • Gastrinoma in men 1 causes multiple, recurrent peptic ulcers in unusual sites with diarrhoea, resistant to standard treatment
  • Men 2 presents with medullary thyroid carcinoma or with the catecholamine symptoms of phaeochromocytoma
  • Men 2B has the worst prognosis, with medullary carcinoma appearing in infancy; the mucosal neuromas and marfanoid habitus may be recognised before any endocrine problem

Applied Aspects

  • Always exclude phaeochromocytoma before any surgery in a patient with men 2 — operating on an undiagnosed phaeochromocytoma can precipitate a fatal hypertensive crisis
  • Genetic testing of first-degree relatives is mandatory once a proband is identified; RET testing is straightforward and highly informative
  • Prophylactic total thyroidectomy is offered to RET mutation carriers, with the timing determined by the specific codon — in infancy for men 2B
  • Serum calcitonin is used for diagnosis and for surveillance of medullary carcinoma
  • Consider men in anyone with two endocrine tumours, or with a single endocrine tumour at an unusually young age or with a family history — the diagnosis changes management for the whole family, not just the patient
  • Parathyroid disease in men 1 is usually multigland hyperplasia, not a single adenoma, so subtotal or total parathyroidectomy with autotransplantation is required — removing one gland fails
  • Lifelong surveillance is needed, since new tumours continue to arise; biochemical screening is repeated annually with periodic imaging
  • Other familial endocrine syndromes — von Hippel–Lindau (phaeochromocytoma, renal cell carcinoma, haemangioblastoma), neurofibromatosis 1, and Carney complex; the presence of a phaeochromocytoma should always prompt genetic assessment
  • Genetic counselling before testing is essential, since a positive result has implications for insurance, employment and family relationships as well as for health
  • Management should be by a multidisciplinary team — endocrinologist, surgeon, geneticist and pathologist — because no single specialty sees the whole syndrome
  • The pancreatic tumours of men 1 determine survival, since they are often multiple, malignant and difficult to localise — unlike the parathyroid disease, which is readily treated
  • Recurrent peptic ulceration with hypercalcaemia is a classical clue to men 1, and should not be treated as two unrelated problems
  • Men syndromes are rare, but recognising one transforms outcomes for relatives who can be screened and treated before disease develops

All questions in Endocrine, Bone & Breast Pathology

  1. Q1Classify diabetes mellitus. Differentiate type 1 from type 2 and describe the pathogenesis, morphology of complications and acute metabolic emergencies. ★
  2. Q2Classify thyroid disorders. Describe Graves disease, Hashimoto thyroiditis and the carcinomas of the thyroid. ★
  3. Q3Describe Cushing syndrome with its causes and investigation. Add notes on adrenal insufficiency, phaeochromocytoma and pituitary disorders. ★
  4. Q4Classify breast lesions. Describe the risk factors, classification, morphology and prognostic factors of breast carcinoma. ★
  5. Q5Describe the metabolic bone diseases. Add notes on osteomyelitis and the classification and features of bone tumours. ★
  6. SN1Describe the multiple endocrine neoplasia syndromes. ★
  7. SN2Define osteoporosis. Describe its causes, pathogenesis and diagnosis. ★
  8. SN3Describe fibroadenoma of the breast and differentiate it from a phyllodes tumour. ★
  9. SN4Define goitre. Describe the causes and pathogenesis of simple and multinodular goitre. ★
  10. SN5Describe carcinoma of the cervix with its aetiology, precursor lesions and prevention. ★
  11. SN6Describe gestational trophoblastic disease. Differentiate complete from partial mole and add a note on choriocarcinoma.
  12. SN7Describe hypothyroidism and hyperthyroidism with their causes, features and the interpretation of thyroid function tests. ★

Every Pathology chapter →

Scroll to Top